The present invention relates to expandable, polymerizable compositions comprising at least one benzoxazine and at least one cyclic carbonate, to polymerization products of these expandable, polymerizable compositions, to a process for preparing these polymerization products as well as to uses of these expandable, polymerizable compositions. The present invention is based on the surprising finding that copolymerizing benzoxazine monomers with cyclic carbonate monomers results in novel copolymers having unforeseeably high expansion rates, wherein the properties (e.g. solid/brittle, solid/soft, rubbery) of the resulting copolymers can be easily and reproducibly tuned/adjusted, depending on the ratio of the benzoxazine equivalents/cyclic carbonate equivalents present in the composition and copolymer, respectively.

Block copolymers have a general chemical structure of one of the formulas [A].sub.n-[B].sub.m and [B].sub.n-[A].sub.m, wherein block [A] is a poly(2-oxazine) and wherein block [B] is a poly(2-oxazoline). The block copolymers have desired thermogelling and rheological properties and are useful as carrier materials for active ingredients such as drugs, cells, proteins, and other active ingredients.

A lubricating composition comprises at least 50 percent by mass, based on the mass of the composition of an oil of lubricating viscosity and 0.01 to 25 percent by mass, based on the mass of the composition of an oil-soluble poly(2-oxazine) polymer. The polymer has the repeat unit: ##STR00001##
where the number (n) of repeat units is an integer between 4 and 500, such as between 4 and 400. The polymer carries an inorganic or organic nucleophilic polymerisation terminating group (t), and an initiator group (i) connected to the N atom of a repeat unit, the initiator group (i) being effective to initiate the polymerisation of linear, branched or cyclic hydrocarbyl moieties. R.sup.1 comprises a single or a mixture of linear, branched or cyclic hydrocarbyl groups having 1-50 carbon atoms, some or all having 12-50 carbon atoms, or of at least one macro-monomeric hydrocarbyl group with more than 50 carbon atoms.

A method of stabilizing asphaltenes in a petroleum hydrocarbon fluid is disclosed. The method includes contacting the petroleum hydrocarbon fluid with a polybenzoxazine comprising repeating structural units of Formula (I):

##STR00001##

wherein R.sub.1 is hydrogen, a C.sub.1-30 alkyl, a C.sub.3-30 cycloalkyl, a C.sub.6-30 aryl, a C.sub.7-30 alkylarylene, a C.sub.7-30 arylalkyl, a C.sub.5-30 heteroaryl, or a C.sub.3-30 heterocycloalkyl; and R.sub.2 is a C.sub.1-30 alkyl, a C.sub.3-30 cycloalkyl, a C.sub.6-30 aryl, a C.sub.7-30 alkylarylene, a C.sub.7-30 arylalkyl, a C.sub.5-30 heteroaryl, or a C.sub.3-30 heterocycloalkyl.

The present invention provides a resin composition which is highly sensitive and exhibits high chemical resistance even in the case of being baked at a low temperature of 250° C. or less and can suppress the generation of outgas after curing. The present invention is a resin composition which contains (a) an alkali-soluble resin containing polyimide, polybenzoxazole, polyamide-imide, a precursor of any one of these compounds and/or a copolymer of these compounds and (b) an alkali-soluble resin having a monovalent or divalent group represented by the following general formula (1) in a structural unit and in which the modification rate of a phenolic hydroxyl group in the alkali-soluble resin (b) is 5% to 50%.

##STR00001##

(In general formula (1), O represents an oxygen atom. R.sup.1 represents a hydrogen atom or a hydrocarbon group which has 1 to 20 carbon atoms and may be substituted and R.sup.2 represents an alkyl group having 1 to 5 carbon atoms. s and t each independently represent an integer from 0 to 3. Provided that (s+t)≥1. d represents an integer from 0 to 2. u represents an integer from 1 to 2, and * represents a chemical bond.)

Polymeric polyoxazolines of the following structure are disclosed:

##STR00001##

where X is the residue of a polymeric polyol after reaction with a dicarboxylic acid/anhydride; where R.sub.5 is an organic moiety; where Y is an organic moiety containing one or more oxazoline groups; and wherein each R.sub.10 is independently hydrogen or an organic moiety. Methods of making such polyoxazolines and using them in a coating, and packages coated therewith, are also within the scope of the present invention.

Thermosetting resin compositions useful for liquid compression molding encapsulation of a reconfigured wafer are provided. The so-encapsulated molded wafer offers improved resistance to warpage, compared to reconfigured wafers encapsulated with known encapsulation materials.

The invention is directed to a visualizing agent comprising a polyoxazoline molecule and one or more labeling compounds. The visualizing agent can be an ocular staining composition that can be used to stain the vitreous body.

A polyolefin-and-poly (2-alkyl-2-oxazoline) formulation comprising (A) an olefin-based (co) polymer, (B) a poly (2-alkyl-2-oxazoline) (co) polymer, and (C) an antioxidant. Also a method of making the composition; a crosslinked polyolefin product made by curing the composition; manufactured articles comprising a shaped form of the inventive formulation or product; and methods of using the inventive formulation, product, or articles.

Described are conjugates comprising a water-soluble polymer linked to a compound comprising a catechol moiety via a cleavable linkage, wherein the cleavable linkage is formed between the water-soluble polymer and a first phenolic hydroxyl group e of the catechol moiety and a second phenolic hydroxyl group of the catechol moiety is linked to a blocking group wherein the rate of hydrolytic release of the compound comprising the catechol moiety is controlled, at least in part, through structure or design of the blocking group on the second phenolic hydroxyl group of the catechol moiety. Therefore, the rate of hydrolytic release of the compound comprising the catechol moiety can be tuned through structural design of the group on the second phenolic hydroxyl group of the catechol moiety. Compounds used in the synthesis of the described conjugates and methods of using the described conjugate and other compounds in the treatment of dopamine-responsive disorders are also described.